CC
PDSB icon

Corton Capital’s PDS Biotechnology PDSB Stock Holding History

Corton Capital’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,150
Closed -$75.3K – 625
2023
Q4 		$75.3K Sell
15,150
-6,941
-31% -$34.5K 0.02% 554
2023
Q3 		$112K Buy
+22,091
New +$121K 0.06% 380

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Corton Capital's PDSB Position: Q1 2024 in Review

Corton Capital sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 15,150 shares — an estimated $75.3K sold.

Corton Capital first reported a position in PDSB in Q3 2023 and held it in 2 quarters. The position peaked at $112K in Q3 2023. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • Corton Capital reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Corton Capital sold 15,150 PDS Biotechnology shares in Q1 2024, an estimated $75.3K.
  • Corton Capital first reported a position in PDS Biotechnology in Q3 2023 and held it in 2 quarters.
  • Corton Capital's PDS Biotechnology position peaked at $112K in Q3 2023.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on Corton Capital's 13F filing for Q1 2024, filed 15 May 2024.